Literature DB >> 26022403

Do we need tailored smoking cessation interventions for smokers with COPD? A comparative study of smokers with and without COPD regarding factors associated with tobacco smoking.

Eva A M van Eerd1, Carolien R van Rossem, Mark G Spigt, Geertjan Wesseling, Onno C P van Schayck, Daniel Kotz.   

Abstract

BACKGROUND: The prevalence of tobacco smoking in patients with chronic obstructive pulmonary disease (COPD) is high. It is assumed that this group of smokers has more difficulties quitting than smokers without COPD. In order to increase the effectiveness of smoking cessation treatments in smokers with COPD it is important to identify any smoking-related factors which are specific to this group of smokers.
OBJECTIVE: To compare smokers with COPD with smokers without COPD regarding factors associated with tobacco smoking and quitting.
METHODS: We conducted a questionnaire survey in all smoking patients with a recorded diagnosis of COPD from a large Dutch primary health care network. We compared this group with twice as many age-, sex- and health care centre-matched smokers without COPD.
RESULTS: Respondents were 107 smokers with COPD and 86 smokers without COPD. The number of attempts to quit was similar in both groups but more smokers with COPD had ever used pharmacological, behavioural and alternative smoking cessation treatments. Furthermore, smokers with COPD more often received triggers to quit from their environment and from their general practitioner, and they were more concerned about, and aware of, the health risks of smoking. Importantly, smokers with COPD reported higher levels of depression and cigarette dependence and a lower self-efficacy to refrain from smoking than smokers without COPD.
CONCLUSION: Smokers with COPD differ from smokers without COPD on several factors which are associated with tobacco smoking and quitting. Taking into account these differences may help to increase the effectiveness of smoking cessation treatments for the specific group of smokers with COPD.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26022403     DOI: 10.1159/000398816

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  13 in total

1.  Psychological Functioning in Patients With Chronic Obstructive Pulmonary Disease: A Preliminary Study of Relations With Smoking Status and Disease Impact.

Authors:  Amanda R Mathew; Susan E Yount; Ravi Kalhan; Brian Hitsman
Journal:  Nicotine Tob Res       Date:  2019-04-17       Impact factor: 4.244

2.  Recommendations to improve smoking cessation outcomes from people with lung conditions who smoke.

Authors:  Sarah Masefield; Pippa Powell; Carlos Jiménez-Ruiz; Peter Hajek; Keir Lewis; Stefan Andreas; Philip Tønnesen; Onno van Schayck; Christina Gratziou; Bertrand Dautzenberg; Serena Tonstad; Thomas Hering; Stephano Nardini; Monica Fletcher
Journal:  ERJ Open Res       Date:  2016-04-27

3.  Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD.

Authors:  Marcus Stegberg; Mikael Hasselgren; Scott Montgomery; Karin Lisspers; Björn Ställberg; Christer Janson; Josefin Sundh
Journal:  Eur Clin Respir J       Date:  2018-01-04

Review 4.  Treating tobacco dependence: guidance for primary care on life-saving interventions. Position statement of the IPCRG.

Authors:  O C P Van Schayck; S Williams; V Barchilon; N Baxter; M Jawad; P A Katsaounou; B J Kirenga; C Panaitescu; I G Tsiligianni; N Zwar; A Ostrem
Journal:  NPJ Prim Care Respir Med       Date:  2017-06-09       Impact factor: 2.871

5.  Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study.

Authors:  Eva Anne Marije van Eerd; Mette Bech Risør; Mark Spigt; Maciek Godycki-Cwirko; Elena Andreeva; Nick Francis; Anja Wollny; Hasse Melbye; Onno van Schayck; Daniel Kotz
Journal:  NPJ Prim Care Respir Med       Date:  2017-06-23       Impact factor: 2.871

6.  Characteristics and related factors of bronchiectasis in chronic obstructive pulmonary disease.

Authors:  Qihong Yu; Haiying Peng; Bo Li; Hongyu Qian; Hong Zhang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  Experiences of tobacco smoking and quitting in smokers with and without chronic obstructive pulmonary disease-a qualitative analysis.

Authors:  Eva A M van Eerd; Mette Bech Risør; Carolien R van Rossem; Onno C P van Schayck; Daniel Kotz
Journal:  BMC Fam Pract       Date:  2015-11-04       Impact factor: 2.497

8.  Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysis.

Authors:  I Aumann; L Tedja; J M Graf von der Schulenburg
Journal:  Tob Induc Dis       Date:  2016-08-24       Impact factor: 2.600

9.  Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom.

Authors:  Dionne Cw Braeken; Gernot Gu Rohde; Frits Me Franssen; Johanna Hm Driessen; Tjeerd P van Staa; Patrick C Souverein; Emiel Fm Wouters; Frank de Vries
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-14

10.  Promoting smoking abstinence among patients with chronic obstructive pulmonary disease: Initial feasibility.

Authors:  Joanna M Streck; Taylor A Ochalek; Mollie E Miller; Andrew C Meyer; Gary Badger; Charlotte Teneback; Anne Dixon; Stephen T Higgins; Stacey C Sigmon
Journal:  Prev Med Rep       Date:  2018-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.